Automation

Robotic arm, automation
#AI / data analytics / healthtech / informatics #Automation #Drug discovery #Organoids #Webinar

Webinar: Overcome organoid workflow challenges with automation

Hosted by Drug Discovery World and supported by Galatek, this webinar explores how automation and AI enable reliable, scalable models by standardising organoid workflows. Organoids have emerged as powerful in vitro models in disease modelling, drug screening, and regenerative medicine, but their complexity introduces major workflow… Read More

Webinar date:
Supported by Galatek
#News

#Automation #Biopharmaceuticals #Drug discovery #Sustainability

Key themes from ELRIG Drug Discovery 2025

This year’s ELRIG Drug Discovery event, which took place at the ACC in Liverpool, was intended as a celebration of the sector, uniting scientists, academics and industry professionals towards the common goal of improving human health. As such the theme for Drug Discovery 2025 was “A Festival of Life Science”… Read More

#News

Lab automation
#AI / data analytics / healthtech / informatics #Automation #Drug discovery #Organoids #Webinar

Webinar: AI-driven solutions streamline organoid workflows

Hosted by Drug Discovery World and supported by Galatek, this webinar explores how automation and AI enable reliable, scalable models by standardising organoid workflows. Organoids have emerged as powerful in vitro models in disease modelling, drug screening, and regenerative medicine, but their complexity introduces major workflow… Read More

Webinar date:
Supported by Galatek
#News

#AI / data analytics / healthtech / informatics #Automation #Drug discovery #Organoids #Webinar

How automation and AI enable reliable, scalable models

Hosted by Drug Discovery World and supported by Galatek, this webinar explores how automation and AI enable reliable, scalable models by standardising organoid workflows. Organoids have emerged as powerful in vitro models in disease modelling, drug screening, and regenerative medicine, but their complexity introduces major workflow… Read More

Webinar date:
Supported by Galatek
#News

Human brain
#Artificial intelligence (AI) #Automation #Deep learning #Drug discovery #eBook #Machine learning

eBook: AI – Advancing drug discovery and development

Over the last few years artificial intelligence (AI) has emerged as a key trend and an important area for investment in drug discovery, whether in preclinical research workflows, clinical trial design or regulation. “AI is evolving faster than any other lab technology with new models and… Read More

#News

eBook: AI – Advancing drug discovery and development
#Artificial intelligence (AI) #Automation #Deep learning #Drug discovery #eBook #Machine learning

AI – Advancing drug discovery and development

Over the last few years artificial intelligence (AI) has emerged as a key trend and an important area for investment in drug discovery, whether in preclinical research workflows, clinical trial design or regulation.

#DDW eBooks #Intelligence

#AI / data analytics / healthtech / informatics #Automation #Drug discovery #Organoids #Webinar

Standardising organoid workflows: How automation and AI enable reliable, scalable models

Organoids have emerged as powerful in vitro models in disease modelling, drug screening, and regenerative medicine, but their complexity introduces major workflow challenges, from culture variability to labour-intensive handling. This webinar, hosted by DDW and supported by Galatek, explores the evolving landscape of organoid research, identify common bottlenecks in daily… Read More

Webinar date:
Supported by Galatek
#Webinars

AI brain partnership
#AI / data analytics / healthtech / informatics #Automation #Drug discovery #Molecular research

How AI drug discovery is reshaping biopharma 

Dr. Sneha Kumar, Charles River’s Strategic Commercial Lead of Logica, explores the extent of what AI can do in the lab and how drug discovery happens if the technology is integrated at every step.   The urgency of a new approach  The numbers tell a story of stubborn inefficiency: Despite decades… Read More

#Exclusive Content

#Automation #Drug discovery #Lab technology #Labguru #Mergers and acquisitions #Titian

Labguru and Titian Software Rebrand as Cenevo

Titian Software and Labguru have rebranded as Cenevo, bringing together the two companies’ solutions, Labguru and Mosaic, under a new, unified brand.   The combined organisation specialises in lab management systems, automation, orchestration, data management and AI technology.  The new company says that Cenevo software will enable smart connected labs that… Read More

#Business & Investment #News

#Artificial intelligence (AI) #Automation #Automation / robotics #Fundraising #Potato

Autonomous science agent company closes $4.5m seed round

Potato, a technology company focused on building autonomous science agents, has announced $4.5 million in new funding, led by Draper Associates.   The company says the funds will accelerate its mission to automate scientific research.   Potato's AI agents orchestrate scientific workflows and use tools to execute computational and wet lab experiments.  … Read More

#Business & Investment #News

#Automated workflows #Automation #Automation / robotics

Lab automation to optimise data processing and maximise throughput

This advertorial for Tecan appeared in DDW Volume 26 – Issue 1, Winter 2024/25 Read the digital issue Digital tools and walkaway time allow scientists to accelerate their research, says Mukta Acharya, Head of Life Sciences Business Division, Tecan. Life sciences are experiencing a transformative wave of automation, artificial intelligence… Read More

#Exclusive Content

#Automated workflows #Automation #Automation / robotics #Case study #Cell and gene therapy #Cellular assays #Viral vectors

Case study: Automating cell-based assays

A new Case Study is now available to download from Hamilton. Oxford Biomedica is an innovative leading viral vector specialist focused on delivering life-changing therapies to patients. The company works across key viral vector delivery systems (lentiviral-, adeno-associated viral- and adenoviral-based vector systems), providing innovative solutions to cell and gene… Read More

#News

#Automated workflows #Automation #Automation / robotics #Cell and gene therapy #Cellular assays #Viral vectors

Automating cell-based assays to determine viral vector titer

In this Case Study, Oxford Biomedica, an innovative global gene and cell therapy company, describes: The automated system used for a 10-day cell-based workflow required for an analytical test to determine viral vector titer The advantages of Hamilton’s CECULA Graphical User Interface (GUI) for the planning of long-term cell-based assays… Read More

#Resources

AI and robotics
#AI / data analytics / healthtech / informatics #Automation #Biotech #Drug development #Drug discovery #Regulatory

Unsustainable regulatory workloads leave no choice about AI adoption 

To determine where pharma/biopharma regulatory functions see the greatest potential for AI technology, ArisGlobal commissioned an exclusive survey1 of senior regulatory professionals in US pharma and biopharma organisations. The research was conducted in early September 2024. Discussing the findings, Renato Rjavec from ArisGlobal notes that, although plans to invest in regulatory AI… Read More

#Exclusive Content #Regulatory

#AI / data analytics / healthtech / informatics #Alzheimer's #Automation #Biomarkers #Data automation #Data management #Digital biomarkers #Digitalisation #Drug development #Drug discovery #Genetics / genomics #Mass spectrometry / NMR #Neurodegenerative disorders #Neuroscience

New podcast: The far-reaching impact of drug discovery technology

This is the latest episode of the free DDW narrated podcast, titled “The far-reaching impact of drug discovery technology”, which covers three articles written for DDW Volume 24 – Issue 2, Spring 2023 of DDW. They are called: “Accelerating time to market through digitalisation”, “… Read More

#News